CIK: 1008170 - Address: 1172 Castro Street, Mountain View, CA 94040
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1123-1-1-6-1-2-11-4
S%wins61657052576562

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/20/12 19:12
7/18/12
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS.d-3,03630.3633-100-46119D357212109168-10-9-10-7-4-9-7-41-40
7/2/12 21:49
6/27/12
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS.d-1,40028.0033-50-30119D199251194282718682-3-29-40-58-60
6/13/12 13:11
6/11/12
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS.d-1,25925.1833-50-30119D1092221342434640811-11-53-45
2/28/12 14:53
2/27/12
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS.d-1,25025.0033-50-30118D183211228145958698125-10-8-123-9-55
2/24/12 20:38
2/23/12
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS.d-3,10420.6933-150-56118D122155157935552515681-413-4-60
12/17/10 21:35
12/15/10
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS.d-5689.1628-62-35116D572-6563450221-1-414-36-224
5/20/10 17:33
5/18/10
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOCEOS-65013.0033-50-3977D1461885645402073-13-10-46-39-25
9/11/09 18:22
9/9/09
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-2,24511.2333-200-66104D13340248105617892861-4-12-21-15-40
7/24/09 17:57
7/22/09
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-3507.004-50-14304D33-1074892523226-3-1-102419-24
6/16/09 17:47
6/12/09
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-3056.104-50-12354D13-21-10672524432-6111015396
12/15/08 17:38
12/12/08
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-1926.426-30-7402D7821-6-189401971-7-23-37-643
9/3/08 15:40
9/2/08
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-4288.556-50-15281D12458392611-11136-1-6-39-60-29
5/27/08 09:58
5/22/08
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS.m-5566.505-86-23291D6037392128274042-1-6-1213-33-37
4/15/08 16:19
11/28/07
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS.a-2345.303-44-9463D93-3141-8-8-9134-745-8-32
4/8/08 20:39
4/4/08
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS.m-946.504-14-4375D87121917150-2-6-5-72530-28
3/25/08 16:06
11/28/07
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS.ad-5085.323-95-17463D804120133-202-2-1-7941-27
1/18/08 15:08
1/16/08
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-3945.993-66-14395D943131131215-2122144-28
1/15/08 17:04
1/14/08
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-456.002-8-2460D894115156101412256-443-18
11/30/07 18:13
11/28/07
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS.d-5025.323-94-17468D68405772381201-89205
8/9/07 17:00
8/8/07
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS.m-835.535-15-3461D54633311141015-4-10-10-17644
8/2/07 17:46
8/1/07
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-425.624-8-2476D6369265125-22-3103-31658
5/1/07 21:58
4/30/07
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADOP,CEOS-1,1165.582-200-29482D8472572729-21-5-1-417-56
12/4/06 21:21
11/30/06
VVUSVivus IncCAHealthDrugPharmaceutical PreparationsWilson Leland FCADS.d-1844.092-45-6682D-2221-14413161-1-1-2-9-42840

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact